Tag: FDA

FDA: Safety Alert on transmission risk of SARS-CoV-2 virus in fecal microbiota

Editor's Note The Food & Drug Administration on March 23 issued a Safety Alert to inform healthcare providers and patients of the potential risk of transmission of SARS-CoV-2 virus by the use of fecal microbiota for transplantation (FMT), and that the agency has determined that additional safety protections are needed.…

Read More

By: Judy Mathias
March 24, 2020
Share

ASCA releases guidance on necessary surgeries for ASCs during COVID-19 pandemic

Editor's Note In consultation with clinical experts and in response to government guidance that hospitals and ambulatory surgery centers (ASCs) postpone elective surgical procedures during the COVID-19 pandemic, the Ambulatory Surgery Center Association (ASCA) released a statement March 18 on how and when facilities should proceed with cases that should…

Read More

By: Judy Mathias
March 18, 2020
Share

FDA: Class I recall of Alaris Infusion Pump System and Modules

Editor's Note The Food and Drug Administration (FDA) on March 6 identified the recall by Becton Dickinson (BD)/CareFusion 303 of its Alaris System Infusion Pumps and Modules as Class I, the most serious. The recall was initiated because of multiple system errors, software errors, and use-related errors. The errors can…

Read More

By: Judy Mathias
March 9, 2020
Share

FDA, CDC increase access to respirators during COVID-19 outbreak

Editor's Note The Food & Drug Administration (FDA) on March 2 announced that it had joined with the Centers for Disease Control and Prevention (CDC) to make more respirators, including certain N95s, available to healthcare personnel during the coronavirus (COVID-19) outbreak. Currently, the majority of respirators are used in industrial…

Read More

By: Judy Mathias
March 4, 2020
Share

FDA: Class I recall of King Systems’ video laryngoscope adapter

Editor's Note The Food & Drug Administration (FDA) on February 27 identified the recall by King Systems of its King Vision Video Laryngoscope Adapter (size ½) as Class I, the most serious. The recall was initiated because all devices from the affected lots show a reversed image on the display,…

Read More

By: Judy Mathias
March 3, 2020
Share

FDA: Class I recall of Tytek Medical TM-317 PneumoDart-Pneumothorax Needle

Editor's Note The Food & Drug Administration on February 25 identified the recall of Tytek Medical’s TM-317 PneumoDart-Pneumothorax Needle as Class I, the most serious. The recall was initiated because of the risk of blockage in the needles caused by the presence of adhesive from the assembly process. The company…

Read More

By: Judy Mathias
February 27, 2020
Share

FDA: Class I recall of Abbott coronary dilatation catheters

Editor's Note The Food & Drug Administration on February 19 identified the recall by Abbott Vascular of its NC Trek RX and NC Traveler RX Coronary Dilatation Catheters (diameter 4.0 mm, 4.5 mm, and 5.00 mm) as Class I, the most serious. The recall was initiated because of failure of…

Read More

By: Judy Mathias
February 25, 2020
Share

Latest sterilization packaging guideline backed by evidence

In October 2019, AORN released its updated Guideline for Sterilization Packaging, which is based on evidence from peer-reviewed literature. This article includes recommendations from that guideline and addresses common misconceptions about sterilization packaging. Other resources for proper use of sterilization packaging include the Association for the Advancement of Medical Instrumentation…

Read More

By: Susan Klacik, BS, CRCST, ACE, CIS, FCS
February 21, 2020
Share

FDA monitoring coronavirus and its effect on supply chain

Editor's Note The Food & Drug Administration on February 14 announced that it is an active partner in the coronavirus (COVID-19) response. It is working closely with the Department of Health and Human Services and international counterparts to help diagnose, treat, and prevent the disease as well as surveil the…

Read More

By: Judy Mathias
February 19, 2020
Share

FDA: Coronavirus hasn’t led to drug, device shortages, but situation fluid

Editor's Note The Food & Drug Administration (FDA) Commissioner Stephen Hahn says there have been no drug or medical device shortages reported in the US so far amid the coronavirus outbreak, but the situation remains fluid, the February 7 Politico reports. The FDA has pulled its inspectors from China, and…

Read More

By: Judy Mathias
February 12, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat